xiaoxi
Lv6
2120 积分
2024-03-13 加入
-
Regulation & registration of drugs and biologics in Brazil
1个月前
已完结
-
Advanced Therapy Medicinal Products: Clinical, Non-clinical, and Quality Considerations
1个月前
已关闭
-
Regulatory Framework, Challenges, and Initial Strategic Planning for Advanced Therapy Products (PTAs) Development in Brazil
1个月前
已完结
-
早产儿视网膜病变的抗VEGF疗法临床指南》解读
1个月前
已完结
-
Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis
1个月前
已完结
-
Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis
1个月前
已关闭
-
Conbercept versus Laser for the Treatment of Infants with Zone II Retinopathy of Prematurity
1个月前
已完结
-
Ranibizumab for the treatment of retinopathy of prematurity: systematic review and meta-analysis
1个月前
已完结
-
《国际化蓝皮书》:中国医药企业开拓东南亚市场的策略和挑战-2023
1个月前
已关闭
-
Interventions for Dry Eye An Overview of Systematic Reviews
1个月前
已完结